Logo

NAKA

Kindly MD, Inc.

NAKA

Kindly MD, Inc. • NASDAQ
$0.50 ▲ 0.36% (+0.00)
Market Cap $188.06 M
52w High $34.77
52w Low $0.43
Dividend Yield 0%
P/E -0.35
Volume 6.52M
Outstanding Shares 376.12M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $388.209K ▼ $10.792M ▲ $-86.036M ▼ -22.162K% ▼ $-0.424 ▼ $-85.371M ▼
Q2-2025 $408.527K ▼ $2.792M ▲ $-2.414M ▼ -590.851% ▼ $-0.35 ▼ $-2.358M ▼
Q1-2025 $579.655K ▼ $1.613M ▼ $-1.038M ▼ -179.074% ▼ $-0.17 ▼ $-954.865K ▼
Q4-2024 $603.887K ▼ $1.621M ▼ $-1.002M ▲ -165.846% ▼ $-0.166 ▲ $-924.527K ▲
Q3-2024 $647.867K $1.69M $-1.014M -156.536% $-0.17 $-955.215K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $24.185M ▲ $692.422M ▲ $214.859M ▲ $477.562M ▲
Q2-2025 $6.025M ▲ $9.89M ▲ $923.394K ▼ $8.967M ▲
Q1-2025 $1.141M ▼ $2.564M ▼ $1.035M ▼ $1.529M ▼
Q4-2024 $2.274M ▼ $3.678M ▼ $1.11M ▲ $2.568M ▼
Q3-2024 $3.643M $4.324M $840.107K $3.484M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-86.036M ▼ $-13.168M ▼ $-683.78M ▼ $715.108M ▲ $18.16M ▲ $-13.168M ▼
Q2-2025 $-2.414M ▼ $-1.911M ▼ $-2.348M ▼ $9.143M ▲ $4.884M ▲ $-4.259M ▼
Q1-2025 $-1.038M ▼ $-865.083K ▲ $-173.448K ▲ $-94.519K ▼ $-1.133M ▲ $-1.039M ▲
Q4-2024 $-1.002M ▲ $-901.53K ▲ $-388.34K ▼ $-79.45K ▼ $-1.369M ▼ $-1.29M ▼
Q3-2024 $-1.014M $-1.045M $-2.109K $-49.568K $-1.097M $-1.047M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Product Retail Sales
Product Retail Sales
 $0 ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Publicly available historical figures in this data set show effectively no reported revenue and a pattern of losses per share, which is typical of a young or transitioning company still building scale. With the pivot to a Bitcoin treasury model, future income statements are likely to be driven far more by swings in the value of Bitcoin and any related investments than by traditional healthcare revenues. That means reported profit or loss could be quite volatile from year to year, even if the underlying healthcare operations change only slowly. Overall, the story here is about a company still in a build‑out and repositioning phase rather than one with a stable, mature earnings base.

Balance Sheet

Balance Sheet The balance sheet figures shown here are effectively blank, so it is hard to draw firm conclusions from this data alone. Conceptually, after the merger with Nakamoto Holdings, the balance sheet is likely to be dominated by digital assets (primarily Bitcoin) and whatever cash was raised to fund that strategy, with the healthcare clinics and related equipment forming a much smaller portion. This creates a balance sheet that can expand or contract meaningfully with Bitcoin’s price, and whose strength will depend on how much debt, if any, is used to finance those holdings. The key issue to watch is how conservatively or aggressively the company funds its Bitcoin position and whether it maintains enough liquidity to support both its treasury ambitions and its healthcare activities.

Cash Flow

Cash Flow The reported cash flow data here are also essentially blank, which means we do not have a clear historical view of how much cash the company has been generating or burning. In practice, a business like this is likely relying heavily on external financing—equity raises or other capital infusions—to buy Bitcoin and to support its healthcare operations while they scale. Cash outflows will probably be driven by clinic operating costs, technology and staffing for the healthcare side, and purchases of Bitcoin and related investments on the treasury side. Cash inflows, at least in the near term, are more likely to come from capital markets than from recurring operating profits, which underscores the importance of continued access to funding.

Competitive Edge

Competitive Edge Kindly MD now sits at the intersection of two very different competitive arenas. In healthcare, it is a niche player focused on holistic pain management, blending medical care, behavioral health, and alternative therapies aimed at reducing opioid use—a differentiated but crowded and highly regulated market where brand, outcomes, and payer relationships matter. In digital assets, it positions itself as a specialized Bitcoin treasury and ecosystem builder, competing with other public Bitcoin holders, dedicated funds, and now a wide range of Bitcoin‑linked products. Its edge on the crypto side seems to rest on the Bitcoin focus, the ambition to build a broader ecosystem of Bitcoin‑native businesses, and the leadership team’s network within the Bitcoin community. The challenge is that each side—healthcare and Bitcoin—has strong, well‑funded competitors, so execution and clarity of focus will be critical to sustaining any lasting advantage.

Innovation and R&D

Innovation and R&D On the healthcare front, Kindly MD emphasizes an integrated, data‑driven care model that combines primary care, mental health support, and alternative therapies to tackle chronic pain and opioid dependence. The company highlights the use of data analysis and algorithmic guidance to tailor treatment plans, as well as telemedicine to extend reach; if built out, this could create a valuable clinical database and more scalable care protocols. On the Bitcoin side, the innovation is primarily in financial structure and strategy rather than traditional R&D: using a listed company as a vehicle for Bitcoin exposure, aiming to assemble a portfolio of Bitcoin‑centric businesses, and potentially creating new financial products that package Bitcoin into different types of securities. Many of these ideas are still in development, so the true level of innovation will only become clear as concrete products, partnerships, and outcomes are disclosed over time.

Summary

Kindly MD is in the middle of a major transformation from a small, specialized healthcare provider into a hybrid entity whose main identity is now as a Bitcoin treasury company. The available historical financial data provide very limited insight into underlying performance and point to an early‑stage business without stable revenues or profits. Going forward, the company’s reported results and balance sheet will likely be driven heavily by the behavior of Bitcoin and the success of its capital‑raising efforts, while its healthcare arm continues to try to prove out a differentiated, data‑driven pain management model. This dual strategy creates both a distinctive narrative and a high degree of complexity: success depends on executing well in two unrelated, heavily scrutinized sectors—healthcare and cryptocurrency—each with its own regulatory, competitive, and operational risks. For now, the story is more about strategic positioning, innovation, and exposure to Bitcoin than it is about steady, predictable financial fundamentals.

NEWS

November 19, 2025 · 4:30 PM UTC

KindlyMD Reports Third Quarter 2025 Operational and Financial Results

Read more

November 17, 2025 · 11:01 AM UTC

BTC Inc Appoints Brandon Green as Chief Executive Officer

Read more

October 7, 2025 · 8:30 AM UTC

KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility

Read more

October 3, 2025 · 4:05 PM UTC

KindlyMD Secures $200 Million Credit Facility from Two Prime and Completes Convertible Note Redemption

Read more

September 10, 2025 · 4:05 PM UTC

KindlyMD Approved for Options Trading on Nasdaq

Read more